Other key speakers include:
Ann K. Daly PhD, Professor of Pharmacogenetics, Newcastle University, UK
Simone Stahl, Associate Principal Scientist, AstraZeneca, UK
Colin Howes, Associate Research Fellow, Pfizer, UK
Christine M. Hunt, Clinical Safety Systems, GSK, USA
Klaus Olejniczak, Scientific Director, Federal Institute for Drugs and Medical Devices (BfArM), Germany
Michael Merz, Head Safety Networks, Novartis, Switzerland
Christoph Wandel, Safety Science Leader, F. Hoffmann - La Roche Ltd, Switzerland
"Excellent talks and very interesting topics"
"Small but high quality event"
"An interesting idea to co-locate with live safety"
"Good meeting overall, correct pitch for inaugural meeting. I would like to see further DILI conferences"
"Diverse and interesting talks"